Carrick Doses First Patient In CT7439 Phase 1 Trial
23 Sep 2024 //
GLOBENEWSWIRE
Carrick Announces First Patient Dosed in Phase 1b/2 Trial of Samuraciclib
14 Feb 2024 //
GLOBENEWSWIRE
Carrick Announces First Patient Dosed in Phase 2b Clinical Trial of Samuraciclib
15 Dec 2023 //
GLOBENEWSWIRE
Carrick Announces First Patient Dosed in Phase 2 Trial of Samuraciclib
18 Oct 2023 //
GLOBENEWSWIRE
Carrick Therapeutics and Menarini to evaluate breast cancer combo therapy
20 Dec 2022 //
CLINICALTRIALSARENA
Carrick Therapeutics and Menarini to evaluate breast cancer combo therapy
20 Dec 2022 //
CLINICALTRIALSARENA
Pfizer backs $60M infusion into Carrick, teams up on breast cancer treatment
02 Dec 2022 //
ENDPTS